mlsanityData to 14 Oct 2026

Injecting Categorical Labels and Syntactic Information into Biomedical NER

arXiv 2311.03113 ↗First posted 6 Nov 2023cs.CL cs.IR cs.LGcited by 0

Not on the map. Why?

Abstract (arXiv)

We present a simple approach to improve biomedical named entity recognition (NER) by injecting categorical labels and Part-of-speech (POS) information into the model. We use two approaches, in the first approach, we first train a sequence-level classifier to classify the sentences into categories to obtain the sentence-level tags (categorical labels). The sequence classifier is modeled as an entailment problem by modifying the labels as a natural language template. This helps to improve the accuracy of the classifier. Further, this label information is injected into the NER model. In this paper, we demonstrate effective ways to represent and inject these labels and POS attributes into the NER model. In the second approach, we jointly learn the categorical labels and NER labels. Here we also inject the POS tags into the model to increase the syntactic context of the model. Experiments on three benchmark datasets show that incorporating categorical label information with syntactic context is quite useful and outperforms baseline BERT-based models.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 6 of its 14 references that are in the map. First posted on arXiv 6 Nov 2023.

Builds on

6 of 14 references.

References · 6

  1. 2018BERT: Pre-training of Deep Bidirectional Transformers for Language Understandingcited by 40,399
  2. 2019BioBERT: a pre-trained biomedical language representation model for biomedical text miningcited by 1,947
  3. 2019ClinicalBERT: Modeling Clinical Notes and Predicting Hospital Readmissioncited by 493
  4. 2019BERT for Joint Intent Classification and Slot Fillingcited by 196
  5. 2021Entailment as Few-Shot Learnercited by 123
  6. 2019Rethinking Attribute Representation and Injection for Sentiment Classificationcited by 8

Built on by

Not cited yet.